Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LAURIE M MCWILLIAMS

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1699942714
CMS profile
781687
Location
RALEIGH, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$14,890.56

72 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–72 of 72 matching records. This page contains 22 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LAURIE M MCWILLIAMS

NPI 1699942714 · CMS profile ID 781687

Allopathic & Osteopathic Physicians / Allergy & Immunology

RALEIGH, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–72 of 72 matching records. This page contains 22 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1699942714?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LAURIE M MCWILLIAMS, NPI 1699942714, CMS profile ID 781687. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–72 of 72 matching records. This page contains 22 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1699942714?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). LAURIE M MCWILLIAMS, NPI 1699942714, CMS profile ID 781687. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–72 of 72 matching records. This page contains 22 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1699942714?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
LAURIE M MCWILLIAMS, NPI 1699942714, CMS profile ID 781687, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–72 of 72 matching records. This page contains 22 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1699942714?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

72 matching records · $14,890.56 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 72 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–72 of 72.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Regeneron Healthcare Solutions, Inc. $18.0105/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114112743 CMS
Amgen Inc. $10.3205/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111648982 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.7605/08/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137633738 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.4805/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137633740 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.1305/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137633736 CMS
Amgen Inc. $10.8004/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111648980 CMS
GlaxoSmithKline, LLC. $975.0004/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116524570 CMS
Regeneron Healthcare Solutions, Inc. $23.4104/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114112741 CMS
Amgen Inc. $11.7704/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111648978 CMS
PFIZER INC. $22.3903/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131249952 CMS
Genentech USA, Inc. $17.7703/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133052279 CMS
Amgen Inc. $12.0603/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111648976 CMS
Regeneron Healthcare Solutions, Inc. $17.5602/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114112739 CMS
Regeneron Healthcare Solutions, Inc. $23.9402/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114112737 CMS
GlaxoSmithKline, LLC. $33.4302/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116621371 CMS
GENZYME CORPORATION $32.1802/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139858208 CMS
AIMMUNE THERAPEUTICS, INC. $175.0002/07/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146964702 CMS
kaleo, Inc. $16.0102/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126627261 CMS
Philips North America LLC $19.9901/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146872520 CMS
Regeneron Healthcare Solutions, Inc. $21.2001/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114112735 CMS
Amgen Inc. $12.4501/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111648974 CMS
AstraZeneca Pharmaceuticals LP $667.6101/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105882429 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $8,026.01 57
PY2020 $9,236.76 14
PY2021 $15,659.93 26
PY2022 $15,642.51 42
PY2023 $11,055.22 55
PY2024 $14,890.56 72
PY2025 $10,251.29 110

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $2,396.79 2
PY2025 Principal investigator $10,107.65 118
PY2024 Recipient $1,158.27 2
PY2024 Principal investigator $19,962.27 171
PY2023 Principal investigator $40,132.47 108

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

120 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $478.17 12/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184279654
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 12/19/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184277772
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 12/19/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184277776
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 12/19/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184277798
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 12/19/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184277820
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 12/19/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184277842
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 12/19/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184277844
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $478.17 10/27/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184253270
Recipient Regeneron Pharmaceuticals, Inc. $1,459.29 10/01/2025 Covered Recipient Physician DUPIXENT CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184120201
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $544.00 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243561
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $544.00 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243563
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $544.00 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243565
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $544.00 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243567
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $44.80 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243569
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.60 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243571
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33.28 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243573
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243575
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.00 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243577
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.60 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243591
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $44.80 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243611
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243633
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243655
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $49.92 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243677
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.16 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243699
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $44.80 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243709
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243711
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243713
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $49.92 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243715
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.16 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243717
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33.28 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243719
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.00 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243721
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.00 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243723
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.60 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243725
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $44.80 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243727
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243729
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243731
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $49.92 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243733
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.16 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243735
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33.28 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243737
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243739
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.44 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243741
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33.28 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243743
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243745
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.00 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243747
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.12 09/29/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184243763
Principal investigator 1 SANOFI US SERVICES INC. $636.00 09/07/2025 Non-covered Recipient Entity
Allergy Partners Of The Triangle
OBSERVER: A multi-center observational study of ISM patients in the real-world setting No dispute reported 06/30/2026 1226107932
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $478.17 08/28/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184232858
Principal investigator 1 SANOFI US SERVICES INC. $636.00 08/28/2025 Non-covered Recipient Entity
Allergy Partners Of The Triangle
OBSERVER: A multi-center observational study of ISM patients in the real-world setting No dispute reported 06/30/2026 1226107928
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $478.17 07/28/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184220516
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $478.17 07/28/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184220518
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213139
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213141
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213143
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213145
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213147
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213149
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213151
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213153
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213155
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213157
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213159
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 07/07/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184213161
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $544.00 05/05/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184192755
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $544.00 05/05/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184192757
Recipient Regeneron Pharmaceuticals, Inc. $937.50 05/01/2025 Covered Recipient Physician ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184120199
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149404
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149406
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149408
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149410
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149412
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149414
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149416
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149418
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149420
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149422
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149424
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149426
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149428
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149430
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149432
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149434
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149436
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149438
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149440
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149442
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149444
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149446
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149448
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/23/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184149450
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148890
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $39.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148892
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $22.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148894
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148896
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148898
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148900
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148902
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $22.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148904
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148906
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148908
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148910
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148912
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148914
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148916
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148918
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148920
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148922
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148924
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148926
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148928
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148930
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148932
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148934
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $22.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148936
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148938
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148940
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148942
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148944
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148946
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $22.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148948
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/20/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184148950